G-POEM for better blood sugar in diabetic gastroparesis
Part of Digestive system clinical trials.
This trial tests a minimally invasive procedure called G-POEM (gastric peroral endoscopic myotomy) to improve blood sugar control in people with diabetes and severe gastroparesis (delayed stomach emptying). It is for patients whose gastroparesis has not improved with standard treatments and who are willing to use a continuous glucose monitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You have had diabetes for at least 5 years and take insulin in a carefully adjusted regimen.
- You have severe gastroparesis (delayed stomach emptying) that hasn't improved with standard treatments.
- You either already use a continuous glucose monitor (CGM) or are willing to use one during the study.
- Your blood sugar is in the target range (70–180 mg/dL) less than 70% of the time.
- You are not using an automated insulin pump (closed-loop system) and have not had certain stomach surgeries or treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for gastroparesis: a procedure called G-POEM (which opens the stomach's outlet valve) and a feeding tube (PEG-J) that bypasses the stomach. It aims to see which is better at helping food move through the stomach.
This trial looks at a stomach procedure called G-POEM to help relieve symptoms of gastroparesis, which means the stomach empties too slowly. If you’re an adult with confirmed gastroparesis and have been referred for endoscopic treatment, you may be able to take part.
This study uses a non-invasive stomach-mapping test (BSGM) to see if a G-POEM procedure (a treatment for gastroparesis) works well. It may help doctors better understand how the stomach empties after the procedure.
This study looks at how useful the POEM procedure is for people with gut “motility” (trouble moving food through the digestive tract). If you’re already scheduled for POEM, your team will also track how well it helps and whether it’s practical in real care.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
This study looks at whether abnormal function of the pyloric “stomach outlet” muscle is linked to gastroparesis symptoms (slow stomach emptying). It may help researchers better understand what causes symptoms and guide future treatments.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.